Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Payers’ experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia

6 references·3 citing·35 second hop

FromToDepth

this work references cited by second hop

References

2003Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents317 cited
2010Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers287 cited
2010Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers255 cited
2014Dealing with uncertainty and high prices of new medicines: A comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden156 cited
2011What principles should govern the use of managed entry agreements?155 cited
2011A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries138 cited

Cited by

2020Defining the concept of fair pricing for medicines65 cited
2022Current prices versus minimum costs of production for CFTR modulators60 cited
2018Patient-level costs in margin re-excision for breast-conserving surgery58 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work